SpectaCell Launches With €6 Million Seed Round for Cell Therapy Analytics Ghent-based SpectaCell has officially launched with €6 million in Seed funding to advance its next-generation cell analysis platform for immunotherapy development. The company is a spin-out of imec, VIB and Ghent University, led by CEO Tony Montoye. The round was led by imec.xpand, with participation from PMV's Flanders Future Tech Fund, InnovationQuarter Capital, Qbic and VIB. Key takeaway: The syndicate of Flemish research institutes and regional funds backing SpectaCell signals continued investor appetite for picks-and-shovels tools that address quality control and characterisation bottlenecks in the growing cell therapy manufacturing pipeline. Source: EU-Startups Biotech #Funding #Startup 🔗 https://www.eu-startups.com/2026/10/ghent-based-spectacell-launches-with-e6-million-to-advance-its-cell-analysis-platform-for-immunotherapy-development/